5LB-32307-24455
3 vaccinations
6 coded responses
30 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 554 / MN
- Registered
- 2021-03-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-10
Registered in v-safe
-
2021-03-10
Dose 1 — Moderna
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-24
- 2021-04-01
-
2021-04-07
Dose 2 — Moderna
- 2021-04-07
-
2021-04-08
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-04-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tirednessAdult check-in
- 2021-04-10
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-21
- 2021-04-28
-
2021-05-05
Survey response — day 28, dose 2MedDRA: Lethargy, Nasal congestion, Oropharyngeal pain — Feeling: FairFree text: Sore throat, head/nasal congestion, lethargicMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-12
- 2021-07-07
- 2021-10-06
-
2021-12-08
Dose 3 — Pfizer-BioNTech
-
2021-12-13
Survey response — days 1–6 daily, dose 3MedDRA: Nasopharyngitis, Respiratory tract congestion, Rhinorrhoea — Feeling: FairFree text: Cold symptoms: runny nose, congestedMedDRA releases: 2024-11 · check-in free text available
-
2021-12-14
Survey response — days 1–6 daily, dose 3MedDRA: Cough, Nasopharyngitis, Rhinorrhoea — Feeling: GoodFree text: Cold symptoms, runny nose, coughMedDRA releases: 2024-11 · check-in free text available
-
2021-12-15
Survey response — day 7, dose 3MedDRA: Nasopharyngitis — Feeling: GoodFree text: Cold symptomsMedDRA releases: 2024-11 · check-in free text available
- 2021-12-22
- 2022-01-07
- 2022-01-12
-
2022-01-21
Survey response — day 42, dose 3MedDRA: Cough, Fatigue, Nasopharyngitis, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Cold symptoms. Runny nose, cough, congestion, fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-03-11
Survey response — 3 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend schoolFree text: COVID-19MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-10 | Moderna | |
| 2 | 2021-04-07 | Moderna | |
| 3 | 2021-12-08 | Pfizer-BioNTech | No |
Free text
Release 8 — day 28, dose 2
Symptoms: Sore throat, head/nasal congestion, lethargic
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Cold symptoms: runny nose, congested
Systemic reaction (other): Cold symptoms, runny nose, cough
Release 10 — day 7, dose 3
Systemic reaction (other): Cold symptoms
Release 11 — day 42, dose 3
Symptoms: Cold symptoms. Runny nose, cough, congestion, fatigue
Release 11 — 3 months, dose 3
Symptoms: COVID-19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Lethargy | ✓ | ✓ | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Nasopharyngitis | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release